Standard BioTools Market Cap 2010-2024 | LAB
Standard BioTools market cap history and chart from 2010 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Standard BioTools market cap as of September 19, 2024 is $0.78B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.783B | $0.106B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $41.383B | 22.26 |
| Tempus AI (TEM) | United States | $7.730B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.325B | 1178.33 |
| Hims & Hers Health (HIMS) | United States | $3.634B | 211.50 |
| Axonics (AXNX) | United States | $3.540B | 0.00 |
| 10x Genomics (TXG) | United States | $2.829B | 0.00 |
| Enovis (ENOV) | United States | $2.514B | 18.23 |
| Azenta (AZTA) | United States | $2.421B | 137.50 |
| Privia Health (PRVA) | United States | $2.324B | 162.00 |
| IRhythm Technologies (IRTC) | United States | $2.283B | 0.00 |
| Omnicell (OMCL) | United States | $1.997B | 65.79 |
| Schrodinger (SDGR) | United States | $1.517B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.507B | 0.00 |
| Phreesia (PHR) | United States | $1.373B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.693B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.567B | 481.00 |
| Health Catalyst (HCAT) | United States | $0.534B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.408B | 0.00 |
| Talkspace (TALK) | United States | $0.353B | 0.00 |
| Pulmonx (LUNG) | United States | $0.336B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.277B | 0.00 |
| TruBridge (TBRG) | United States | $0.184B | 13.49 |
| P3 Health Partners (PIII) | United States | $0.160B | 0.00 |
| American Well (AMWL) | United States | $0.149B | 0.00 |
| Augmedix (AUGX) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.084B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.054B | 0.00 |
| 111 (YI) | China | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| CareCloud (CCLD) | United States | $0.047B | 0.00 |
| Movano (MOVE) | United States | $0.036B | 0.00 |
| Outset Medical (OM) | United States | $0.031B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.024B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |